Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved ...
However, there are subtypes of both cancers, and these subtypes can also affect different age groups. For example, chronic leukemias are more likely to affect older adults. Hodgkin lymphoma is the ...